TFA Therapeutics (RAJAF) Income from Discontinued Operations (2021 - 2023)
TFA Therapeutics (RAJAF) posted Income from Discontinued Operations of -$25814.0 for Q4 2023, up 91.54% on a QoQ basis from -$304982.0 in Q4 2022, and up 91.54% year-over-year from -$13477.4 in Q4 2022.
Powered by 
Analysis
TFA Therapeutics (RAJAF) Income from Discontinued Operations (2021 - 2023) Analysis & Trends
TFA Therapeutics has reported Income from Discontinued Operations for 3 years, with the latest figure at -$25814.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | - |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | - |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | -60.00 Mn |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | - |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | -14.10 Mn |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | 1.40 Mn |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | - |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 682.25 Mn | 576.35 Mn | 40.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -25,814.00 |
| Dec 31, 2022 | -304,982.00 |
| Dec 31, 2021 | -371,626.00 |